Concepedia

Xiangling Xiao

XX

Statistics

Publications

13

Citations

629

H-Index

11

Active since

2016

Affiliations

Zhongnan Hospital of Wuhan University(Current)

Wuhan University

Harvard University

Institute of Biomedical Sciences, Academia Sinica

Beth Israel Deaconess Medical Center

Xiangling Xiao is an author at Zhongnan Hospital of Wuhan University specializing in medicine, pharmacology, and ophthalmology.

ORCID

Top concepts

Publications per year

2016–2025

13

Publications

13

USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy

Wenjun Xiong, Xueliang Gao, Tiantian Zhang et al. · Nature Communications · 2022 · 138 citations · Full text

USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy

H. Li, Yishuang Sun, Yingmeng Yao et al. · Proceedings of the National Academy of Sciences · 2024 · 100 citations · Full text

Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy

Haisheng Yu, Jing Liu, Xia Bu et al. · Cell chemical biology · 2023 · 78 citations · Full text

ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy

Xiangling Xiao, Jie Shi, Chuan He et al. · Nature Communications · 2023 · 73 citations · Full text

Oridonin inhibits gefitinib-resistant lung cancer cells by suppressing EGFR/ERK/MMP-12 and CIP2A/Akt signaling pathways

Xiangling Xiao, Zhongwei He, Wei Cao et al. · International Journal of Oncology · 2016 · 62 citations · Full text

, , +15

1–5 of 13